Success Story: Dual Victory: NIW Approval Followed by EB-1A Success for an Artificial Intelligence in Healthcare Researcher
Client’s Testimonial:
"Thank you again for all your help throughout this process!”
On June 20th, 2026, and June 2nd, 2026, we received EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approvals for an Artificial Intelligence Scientist in the Field of Artificial Intelligence in Healthcare (Approval Notice).
General Field: Artificial Intelligence in Healthcare
Position at the Time of Case Filing: Artificial Intelligence Scientist
Country of Origin: China
State of Residence at the Time of Filing: Washington
Approval Notice Date: June 20th, 2026 (NIW); June 2nd, 2026 (EB-1A)
Processing Time: 22 months, 27 days (NIW); 13 months, 1 day (EB-1A) (Premium Processing Upgrade Requested)
Case Summary:
Our firm had the privilege of guiding this client through two major immigration milestones: securing his I-140 EB-1A approval in June 2026 and subsequently receiving approval of his I-140 NIW petition later that same month.
Advancing Artificial Intelligence in Healthcare
The petitioner, equipped with a Ph.D. in computational science, has built a strong research record in artificial intelligence (AI) in healthcare. At the time of filing, he was working as an AI Scientist, where his work involved developing deep learning models to extract, interpret, and summarize medical data for downstream healthcare applications.
His proposed endeavor centered on developing state-of-the-art deep learning methods to provide richer insights into human diseases from medical data, with the goal of enhancing precision healthcare, clinical trial design, and drug development. We demonstrated under the Dhanasar framework that this work has substantial merit and national importance because it supports progress in medical artificial intelligence, predictive modeling, disease analysis, and healthcare innovation.
To contextualize the significance of his work, we presented 4 recommendation letters from experts in the field and explained how his research helps address disease complexity through advanced analysis of medical imaging, genetic information, and other clinical data. One expert noted:
“In conclusion, [Client’s] research significantly advances disease diagnostics, personalized treatment approaches, and predictive modeling, demonstrating his ongoing leadership in these critical areas”
A Strong Record of Peer Recognition and Independent Reliance
To satisfy the NIW requirements and later demonstrate the client’s extraordinary ability for EB-1A, we carefully organized his objective record of achievement:
- Publication Record: We highlighted that the client had documented his research in 16 peer-reviewed journal articles, 1 peer-reviewed conference paper, 5 abstracts, 1 preprint, and 1 book chapter.
- Citation Metrics: We demonstrated that his published work had been cited 570 times, reflecting meaningful reliance by researchers in artificial intelligence, medical imaging, disease modeling, and precision healthcare.
- Peer Review Authority: We showcased his service as a judge of his peers’ work, including at least 20 completed peer reviews for respected journals and conferences.
Beyond listing these achievements, we showed how the client’s research influenced the field, including contributions to deep learning for medical imaging, and interpretable disease modeling. We also highlighted that several of his papers ranked among highly cited publications, demonstrating strong recognition.
By combining his academic background, research role, publication record, citations, peer review service, and recommendation letters, we established both the national importance of his work for NIW and his sustained acclaim for EB-1A. We are pleased to have secured both approvals and look forward to his continued contributions to AI in healthcare.